NK, Y., T, A., IJ, M., & ML, L. (2021). Pembrolizumab-induced autoimmune haemolytic anemia in a patient with chronic lymphocytic leukaemia successfully treated with ibrutinib. BMJ case reports, 14(9), . https://doi.org/10.1136/bcr-2021-245350
Chicago Style (17th ed.) CitationNK, Yun, Alrifai T, Miller IJ, and Larson ML. "Pembrolizumab-induced Autoimmune Haemolytic Anemia in a Patient with Chronic Lymphocytic Leukaemia Successfully Treated with Ibrutinib." BMJ Case Reports 14, no. 9 (2021). https://doi.org/10.1136/bcr-2021-245350.
MLA (9th ed.) CitationNK, Yun, et al. "Pembrolizumab-induced Autoimmune Haemolytic Anemia in a Patient with Chronic Lymphocytic Leukaemia Successfully Treated with Ibrutinib." BMJ Case Reports, vol. 14, no. 9, 2021, https://doi.org/10.1136/bcr-2021-245350.